 | Registration No.: | 21PIP567 |
| Name: | Varma Tanmaykumar Mukeshbhai |
|---|
| Ph.D. Thesis Title: | In silico Exploration of Chemical Space for Dual Inhibitor of GSK3β and BACE1 as Potential Medication for Alzheimer's Disease |
|---|
| Connect at: | Linkedin |
|---|
| Research: 12 |
|---|
| Rajkumar R, Varma T, Garg P. Discovery of Putative G-Protein-Biased μ-Opioid Agonists via Hierarchical Virtual Screening of Ultra-Large Chemical Space. Molecular Diversity 2026, . |
| Shahiwala A, Al-Helo H, Desai S, Vahora H, Varma T, Garg P. Molecular Docking and Dynamics of Natural Compounds Targeting Iron and Erythropoietic Pathways in β-Thalassemia. In Silico Research in Biomedicine 2026, 2: 100220. |
| Kamble P, Varma T, Kumar R, Garg P. Computational Theranostics Strategy for Pancreatic Ductal Adenocarcinoma. Molecular Diversity 2025, 29: . |
| Nagare SD, Desai SA, Patel VP, Sapkal S, More M, Kate Aditi, Shahiwala AF, Varma Tanmaykumar T, Garg Prabha. Developing a Predictive QSAR Model for FGFR-1 Inhibitors: Integrating Computational and Experimental Validation. Journal of Computer-Aided Molecular Design 2025, 39: 89. |
| Rajkumar R, Sharma A, Badade A, Varma T, Garg P. OpioidBias: A Machine Learning Framework for Predicting Biased Agonism of Opioid Ligands. ACS Medicinal Chemistry Letters 2025, 16: 2467-2476. |
| Shah AJ, Dar MY, Adnan M, Varma T, Agarwal D, Garg P, Mir RH, Meena R, Masoodi MH. Integration of Phytochemical Profiling and Computational Approaches to Evaluate the Neuroprotective Potential of Nardostachys jatamansi in Alzheimer's Disease. Biotechnology Reports 2025, 45: e00881. |
| Shankar G, Kumar P, Rai S, Ghosh A, Varma T, Wani MA, Kumar S, Mandloi U, Singh GK, Garg P, Kulkarni O, Srikrishna S, Kumar S, Modi G. Discovery of novel hybrid tryptamine-rivastigmine molecules as a potent AChE and BChE inhibitors exhibiting multifunctional properties for the management of Alzheimer’s disease. European Journal of Medicinal Chemistry 2025, 283: 117066. |
| Varma T, Kamble P, Garg P. Rational Discovery of BACE1-Selective Inhibitors as Potential Therapeutics for Alzheimer’s Disease. Drug Development Research 2025, 86: e70169. |
| Varma T, Kamble P, Rajkumar R, Garg P. Computational discovery of ATP-competitive GSK3β inhibitors using database-driven virtual screening and deep learning. Molecular Diversity 2025, . |
| Nilakhe A, Gupta S, Rai H, Varma T, Garg P, Modi G, Singh R, Kumar P, Rai S, Debnath J et al. Rhodanine composite fluorescence probes to detect amyloid-beta aggregated species in Alzheimer's disease models. Sensors and Actuators B: Chemical 2024, 407: 135364. |
| Wankhade N, Dayasagar U, Sharma A, Kamble P, Varma T, Garg P. DeepADRA2A: predicting adrenergic α2a inhibitors using deep learning. Journal of Biomolecular Structure and Dynamics 2024, 42: 12353-12364. |
| Heyns I, Ganugula R, Varma T, Allamreddy S, Kumar N, Garg P, Kumar MNVR, Arora M. Rationally Designed Naringenin-Conjugated Polyester Nanoparticles Enable Folate Receptor-Mediated Peroral Delivery of Insulin. ACS Applied Materials & Interfaces 2023, 15: 45651-45657. |
| Books/Book Chapters: 2 |
|---|
| Gahlawat A, R R, Varma T, Kamble P, Banerjee A, Sandhu H, Garg P. Bioinformatics: Theory and Applications. In The Quintessence of Basic and Clinical Research and Scientific Publishing 2023. Edited By Jagadeesh G, Balakumar P, Senatore F. |
| Varma T, Kamble P, Kumari M, Diwakar V, Garg P. Vitamin-Based Derivatives for the Management of Alzheimer’s Disease. In Natural Product-based Synthetic Drug Molecules in Alzheimer's Disease 2023. Edited By Sharma A, Modi GP. |